By Professor Michelle Haber

Book Chapters

Xu N; Tse B; Yang L; Tang TCY; Haber M; Micklethwaite K; Dolnikov A, 2022, 'Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy: A Recent Study', in Current Innovations in Medicine and Medical Science Vol. 3, Sciencedomain International, pp. 61 - 87, http://dx.doi.org/10.9734/bpi/cimms/v3/7736f

Burkhart CA; Haber M; Norris MD; Gudkov AV; Nikiforov MA, 2021, 'Cell-based methods for the identification of Myc-inhibitory small molecules', in The Myc Gene: Methods and Protocols, pp. 337 - 346, http://dx.doi.org/10.1007/978-1-0716-1476-1_19

Fletcher J; Roundhill E; Haber M; Norris M, 2014, 'Clinical relevance of multidrug-resistance-proteins (MRPs) for anticancer drug resistance and prognosis', in Efferth T; Bonavida B (ed.), Resistancce to Targeted Anti-Cancer Therapeutics, Springer Press., pp. 27 - 52

Norris MD; Burkhart CA; Haber M; Gudkov AV; Nikiforov MA, 2013, 'Cell-Based Methods for the Identification of MYC-Inhibitory Small Molecules', in Soucek L; Sodir NM (ed.), The Myc Gene, Humana Press Inc, pp. 255 - 264, http://dx.doi.org/10.1007/978-1-62703-429-6_18

Cheung L; Murray JE; Norris MD; Haber M, 2013, 'Oncogene and Cancer - From Bench to Clinic', in Siregar YE; norris (ed.), Oncogene and Cancer - From Bench to Clinic, Inst za onkologiju i radiol, pp. 437 - 454, http://dx.doi.org/10.5772/54813

Xue C; Gudkov A; Haber M; Norris MD, 2012, 'Small molecule drugs and targeted therapies for neuroblastoma', in Shimada H (ed.), Neuroblastoma - Present and Future, In Tech, Croatia, pp. 299 - 324, http://www.amazon.com/Neuroblastoma-Present-and-Future-ebook/dp/B00CBWQI92/ref=sr_1_1?ie=UTF8&qid=1366940364&sr=8-1&keywords=neuroblastoma+-+present+and+future#reader_B00CBWQI92

Fletcher JI; Haber M; Henderson M; Norris MD, 2012, 'Targeting Multidrug Resistance in Neuroblastoma', in Hayat MA (ed.), Pediatric Cancer Volume 1 Diagnosis, Therapy and Prognosis: Neuroblastoma, Springer, New York, USA, pp. 115 - 123, http://dx.doi.org/10.1007/978-94-007-2418-1_11

Burkhart CA; Haber M; Norris MD; Gudkov AV; Nikiforov MA, 2012, 'The Myc Gene: Methods and Protocols: Myc inhibitory molecules', in Methods in Molecular Biology, Humana Press

Haber M; Kavallaris M, 2000, 'Multidrug Resistance Genes in Neuroblastoma', in Neuroblastoma, Elsevier Science BV, Amsterdam, pp. 207 - 215

Journal articles

Dorstyn L; Puccini J; Nikolic A; Shalini S; Wilson CH; Norris MD; Haber M; Kumar S, 2026, 'Correction: An unexpected role for caspase-2 in neuroblastoma (Cell Death & Disease, (2014), 5, 8, (e1383), 10.1038/cddis.2014.342)', Cell Death and Disease, 17, http://dx.doi.org/10.1038/s41419-026-09023-2

McKay CJL; Mayoh C; Power P; Jessop S; Sriharan S; Staunton J; Trinder S; Zhukova N; Mignone C; Govender D; Alvaro F; Downie P; Hansford JR; Hassall T; Valvi S; Mateos MK; Barahona P; Gifford AJ; Tax G; Tsoli M; Dolman EM; Wong M; Cowley M; Marshall GM; Trahair TN; Ekert PG; Haber M; Tyrell V; Lau LMS; Manoharan N; Ziegler DS; Khuong-Quang DA, 2026, 'Precision-guided therapy in H3K27-altered diffuse midline glioma', Nature Communications, 17, http://dx.doi.org/10.1038/s41467-026-73304-9

Soria-Bretones I; Casás-Selves M; Samanta M; Groff D; Murray J; Fletcher JI; Farrel A; Pastor S; Patel K; Goodfellow E; Li L; Caron C; Shiwram A; Kim H; Henry D; Laterreur N; Bowlan J; Krytska K; Neuhauser SB; Stearns TM; Schubert JA; Wu J; Surrey LF; Martinez D; Mak C; Brand J; Wesley C; Somers K; Álvarez-Quilón A; Vallée F; Nejad P; Schonhoft JD; Li J; Veloso A; Young JTF; Hyer ML; Morris SJ; Mossé YP; Marshall CG; Haber M; Zimmermann M; Maris JM, 2026, 'The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity', Nature Communications, 17, http://dx.doi.org/10.1038/s41467-026-74061-5

Hetherington K; Hunter JD; Donoghoe MW; McGillycuddy M; McGill BC; Robertson EG; Tyrrell V; Lau LMS; Marron JM; Tucker KM; Marshall GM; Vetsch J; Haber M; Malkin D; Mateos MK; O’Brien TA; Ziegler DS; Wakefield CE, 2026, 'Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancer', npj Genomic Medicine, http://dx.doi.org/10.1038/s41525-026-00591-y

Fordham AM; Brown LM; Mayoh C; Salib A; Barger ZA; Wong M; Lim Kam Sian TCC; Hu C; Xie J; Gunther K; Trebilcock P; Terry RL; Barahona P; Ajuyah P; Sherstyuk A; Avila A; Cadiz R; Perkins CM; Gifford AJ; Mao J; Dolman MEM; Zhao A; O’Regan LP; Gorgels D; Lau LMS; Ziegler DS; Haber M; Tyrrell V; Lock RB; Cowley MJ; Nicholls W; Daly RJ; Ekert PG; Fleuren EDG, 2026, 'Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young', Molecular Cancer Therapeutics, 25, pp. 1077 - 1094, http://dx.doi.org/10.1158/1535-7163.mct-25-0736

Hetherington K; Hunter J; Donoghoe M; McGillycuddy M; McGill B; Robertson E; Tyrrell V; Lau L; Marron J; Tucker K; Marshall G; Vetsch J; Haber M; Malkin D; Mateos M; Brien TO; Ziegler D; Wakefield C, 2026, 'ID #107 Family experiences of precision-guided treatment recommendations for poor prognosis paediatric Central Nervous System (CNS) cancer', Neuro-Oncology Pediatrics, 2, pp. wuag026.020, http://dx.doi.org/10.1093/neuped/wuag026.020

Mateos M; Manoharan N; Anh D; Quang K; Chen W; Salomon R; Shale C; Ong F; Sriharan S; Valvi S; Nicholas S; Mayoh C; Toumari M; Li W; El-Kamand S; Wong M; Hansford J; Alvaro F; Bazaz SR; Cui L; Tyrrell V; Cuppen E; Haber M; Ekert P; Priestley P; Ziegler D; Lau L; Cowley M, 2026, 'ID #736 Ultra-sensitive plasma ctDNA assay enables detection of brain tumour DNA in peripheral blood and is prognostic in childhood brain cancer', Neuro-Oncology Pediatrics, 2, pp. wuag026.309, http://dx.doi.org/10.1093/neuped/wuag026.309

Karsa M; Karsa A; Spurling D; Xiao L; Ronca E; Bongers A; Gao W; Gifford AJ; El-Ayoubi A; Cheung LC; Kotecha RS; Lock RB; Teh CE; Lessene G; Norris MD; Wei A; Haber M; Henderson MJ; Moujalled DM; Somers K, 2026, 'BCL-2 and MCL1 co-inhibition enhances glucocorticoid therapy in preclinical models of infant KMT2A-rearranged acute lymphoblastic leukaemia', British Journal of Haematology, http://dx.doi.org/10.1111/bjh.70598

Fuentes-Bolanos NA; Courtney EK; Mayoh C; Warby M; Lau LMS; Wong-Erasmus M; Khuong-Quang DA; Barahona P; Padhye B; Warren N; El-Kamand S; Nunag S; Ajuyah P; Sherstyuk A; Altekoester AK; Sullivan A; Poplawski N; Kiraly-Borri C; O’sullivan S; Fan HM; Alli R; Curnow L; Bhatia K; Anazodo A; Trahair TN; Mateos MK; Hansford JR; Dholaria H; Josephi-Taylor S; Moore AS; Nicholls W; Gottardo NG; Downie P; Khaw SL; Tapp H; McCowage G; Dalla-Pozza L; Alvaro F; Wood PJ; Tyrrell V; Haber M; Cowley MJ; Ekert PG; Marshall GM; Kirk J; Tucker K; Pinese M; Ziegler DS, 2026, 'Integrated Germline and Somatic Molecular Profiling to Detect Cancer Predisposition Has a High Clinical Impact in Poor-Prognosis Pediatric Cancer', Clinical Cancer Research, 32, pp. 2047 - 2059, http://dx.doi.org/10.1158/1078-0432.CCR-25-3806

Haber M; Norris MD, 2026, 'Altering the Diet to Rewire Cancer', New England Journal of Medicine, 394, pp. 1447 - 1450, http://dx.doi.org/10.1056/NEJMcibr2516825

Chen J; Nelson C; Wong M; Tee AE; Liu PY; La T; Fletcher JI; Kamili A; Mayoh C; Bartenhagen C; Trahair TN; Xu N; Jayatilleke N; Wong M; Peng H; Atmadibrata B; Cheung BB; Lan Q; Bryan TM; Mestdagh P; Vandesompele J; Combaret V; Boeva V; Wang JY; Janoueix-Lerosey I; Cowley MJ; Mackenzie KL; Dolnikov A; Li J; Polly P; Marshall GM; Reddel RR; Norris MD; Haber M; Fischer M; Zhang XD; Pickett HA; Liu T, 2026, 'Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy (Clin Cancer Res, (2021), 27, (1438–1451), 10.1158/1078-0432.CCR-20-3044)', Clinical Cancer Research, 32, pp. 1182, http://dx.doi.org/10.1158/1078-0432.CCR-26-0621

Hanssen KM; Murray J; Pandher R; Alfred S; Gamble LD; Brand J; Mosmann E; Kusuma FK; Mak C; Kearns A; Kamili A; Atkinson C; Minchaca AZ; Bertoldo J; Ziegler DS; Mussai F; Cheng PNM; Norris MD; Fletcher JI; Haber M, 2025, 'Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma', Journal of Experimental and Clinical Cancer Research, 44, http://dx.doi.org/10.1186/s13046-025-03502-8

Atkinson C; Kamili A; Tactacan CM; Jayatilleke N; Rosser SPA; Saletta F; Gana CC; Graber P; Wanninayaka A; Ignacio RMC; Kavallaris M; Gifford AJ; Lock RB; Norris MD; Haber M; Mayoh C; Nath CE; Trahair TN; Fletcher JI, 2025, 'P-glycoprotein as a chemotherapy resistance mechanism and biomarker of poor response in high-risk neuroblastoma', Ejc Paediatric Oncology, 6, pp. 100478, http://dx.doi.org/10.1016/j.ejcped.2025.100478

Lei Y; Hetherington K; Daly R; Rensen N; McGill BC; Ziegler DS; Lau LMS; Tyrrell V; Karpelowsky J; Cowley MJ; Tucker KM; Haber M; Barahona P; Wakefield CE, 2025, 'Data Sharing, Biopsies and Patient Confidentiality in a Precision Medicine Trial for Childhood Cancer: A Mixed Method Study of Parents, Oncologists, and Scientists’ Perspectives', Journal of Personalized Medicine, 15, http://dx.doi.org/10.3390/jpm15110531

Lau LMS; Salomon R; Chen W; Shale C; Toumari M; Li W; Chan J; Razavi-Bazaz S; Cui L; El-Kamand S; Wong M; Cuppen E; Haber M; Tyrrell V; Ekert PG; Ziegler DS; Priestley P; Cowley MJ, 2025, 'Abstract A001-PR009: Whole-genome-based, tumor-informed circulating tumor DNA detection correlates with treatment response and survival of pediatric solid tumor', Cancer Research, 85, pp. a001-pr009-a001-pr009, http://dx.doi.org/10.1158/1538-7445.pediatric25-a001-pr009

Raiti L; Altekoester A; El-Kamand S; Ryan G; Tucker K; Warby M; Courtney E; Barahona P; Lau L; Trahair T; Marshall G; Ziegler D; Haber M; Tyrrell V; Cowley M; Mayoh C; Pinese M; Khuong-Quang D-A; Fuentes-Bolanos N, 2025, 'Abstract A044: The biology of childhood tumors with germline CHEK2 loss of function variants', Cancer Research, 85, pp. a044 - a044, http://dx.doi.org/10.1158/1538-7445.pediatric25-a044

Fuentes-Bolanos NA; Sylvester D; Courtney E; Mayoh C; Warby M; Khuong Quang DA; Barahona P; Sullivan A; Altekoester A; Rumford M; Dholaria H; Wong M; Tyrrell V; Haber M; Tucker K; Cowley MJ; Ziegler DS; Pinese M; Lau LMS, 2025, 'Abstract A045: Cooperation between germline and somatic drivers in childhood cancer: insights from the ZERO cohort', Cancer Research, 85, pp. a045 - a045, http://dx.doi.org/10.1158/1538-7445.pediatric25-a045

Body A; Lal L; Downie P; Anazodo A; O’Brien T; Padhye B; Fuentes-Bolanos N; Srihari S; Ahern ES; Haber M; Smith C; Lineburg K; Turville S; Naing Z; Rawlinson W; Buttery J; Raina MacIntyre C; Milch V; Segelov E, 2025, 'Immune Response to COVID-19 Vaccination in Children With Cancer', Pediatrics, 156, http://dx.doi.org/10.1542/peds.2024-070209

Azzam N; Fletcher JI; Melong N; Lau LMS; Dolman EM; Mao J; Tax G; Cadiz R; Tuzi L; Kamili A; Dumevska B; Xie J; Chan JA; Senger DL; Grover SA; Malkin D; Haber M; Berman JN, 2025, 'Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy', Cancer Research Communications, 5, pp. 1215 - 1227, http://dx.doi.org/10.1158/2767-9764.CRC-25-0080

Sansom-Daly UM; McLoone JK; Fardell JE; Evans HE; McGill BC; Robertson EG; Signorelli C; Ellis S; Ha L; Hetherington K; Houweling RE; Nevin SM; Schilstra CE; Mitchell R; Haber M; Cohn RJ; Wakefield CE, 2025, 'Bridging the Gap: Embedding Psychosocial Oncology Research into Comprehensive Cancer Care for Children and Young People', Cancers, 17, pp. 2123 - 2123, http://dx.doi.org/10.3390/cancers17132123

Pandher R; Xue C; Gamble LD; Milazzo G; Giacomo SD; Murray J; Cheung L; Ferrucci F; Palombo M; Purgato S; Burkhart CA; Fedtsova N; Gleiberman AS; Purmal AA; Korotchkina L; Nikiforov MA; Makarov SS; Telfer TJ; Codd R; Marshall GM; Scott DA; Osterman AL; Gudkov AV; Perini G; Haber M; Norris MD, 2025, 'The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response', Proceedings of the National Academy of Sciences of the United States of America, 122, http://dx.doi.org/10.1073/pnas.2420011122

Azfar M; Gao W; Van den Haute C; Xiao L; Karsa M; Pandher R; Karsa A; Spurling D; Ronca E; Bongers A; Guo X; Mayoh C; Fayt Y; Schoofs A; Burns MR; Verhelst SHL; Norris MD; Haber M; Vangheluwe P; Somers K, 2025, 'The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastoma', Molecular Oncology, 19, pp. 913 - 936, http://dx.doi.org/10.1002/1878-0261.13789

Gao W; Karsa M; Xiao L; Spurling D; Karsa A; Ronca E; Bongers A; Guo X; Mayoh C; Azfar M; Verhelst SHL; Tanaka K; Cheung LC; Kotecha RS; Lock RB; Burns MR; Vangheluwe P; Norris MD; Haber M; Somers K, 2025, 'Polyamine depletion limits progression of acute leukaemia', International Journal of Cancer, http://dx.doi.org/10.1002/ijc.35362

Han JZR; Phimmachanh M; Hastings JF; Leong KH; Ng BH; Ni J; Fontaine-Titley A; Cadell AL; O’Donnell YE; Clearwater M; Kamili A; Haber M; Norris M; Timpson P; Trahair TN; Fletcher JI; Fey D; Kolch W; Latham SL; Croucher DR, 2025, 'Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma', Science Advances, 11, http://dx.doi.org/10.1126/sciadv.ady5599

Rouaen JRC; Salerno A; Shai-Hee T; Murray JE; Castrogiovanni G; McHenry C; Jue TR; Pham V; Bell JL; Poursani E; Valli E; Cazzoli R; Damstra N; Nelson DJ; Stevens KLP; Chee J; Slapetova I; Kasherman M; Whan R; Lin F; Cochran BJ; Tedla N; Veli FC; Yuksel A; Mayoh C; Saletta F; Mercatelli D; Chtanova T; Kulasinghe A; Catchpoole D; Cirillo G; Biro M; Lode HN; Luciani F; Haber M; Gray JC; Trahair TN; Vittorio O, 2024, 'Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma', Nature Communications, 15, pp. 10462, http://dx.doi.org/10.1038/s41467-024-54689-x

Cheung BB; Mittra R; Murray J; Wang Q; Seneviratne JA; Raipuria M; Wong IPL; Restuccia D; Gifford A; Salib A; Sutton S; Huang L; Ferdowsi PV; Tsang J; Sekyere E; Mayoh C; Luo L; Brown DL; Stow JL; Zhu S; Young RJ; Solomon BJ; Chappaz S; Kile B; Kueh A; Herold MJ; Hilton DJ; Liu T; Norris MD; Haber M; Carter DR; Parker MW; Marshall GM, 2024, 'Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesis', Communications Biology, 7, pp. 1322, http://dx.doi.org/10.1038/s42003-024-06899-8

Nelson CB; Rogers S; Roychoudhury K; Tan YS; Atkinson CJ; Sobinoff AP; Tomlinson CG; Hsu A; Lu R; Dray E; Haber M; Fletcher JI; Cesare AJ; Hegde RS; Pickett HA, 2024, 'The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-45683-4

Murray JE; Valli E; Milazzo G; Mayoh C; Gifford AJ; Fletcher JI; Xue C; Jayatilleke N; Salehzadeh F; Gamble LD; Rouaen JRC; Carter DR; Forgham H; Sekyere EO; Keating J; Eden G; Allan S; Alfred S; Kusuma FK; Clark A; Webber H; Russell AJ; de Weck A; Kile BT; Santulli M; De Rosa P; Fleuren EDG; Gao W; Wilkinson-White L; Low JKK; Mackay JP; Marshall GM; Hilton DJ; Giorgi FM; Koster J; Perini G; Haber M; Norris MD, 2024, 'The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-49871-0

Seneviratne JA; Ravindrarajah D; Carter DR; Zhai V; Lalwani A; Krishan S; Balachandran A; Ng E; Pandher R; Wong M; Nero TL; Wang S; Norris MD; Haber M; Liu T; Parker MW; Cheung BB; Marshall GM, 2024, 'Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma', Cancer Medicine, 13, pp. e70082, http://dx.doi.org/10.1002/cam4.70082

Hu W; Kumar A; Ahmed SF; Qi S; Ma DKG; Chen H; Singh GJ; Casan JML; Haber M; Voskoboinik I; McKay MR; Trapani JA; Ekert PG; Fareh M, 2024, 'Single-base tiled screen unveils design principles of PspCas13b for potent and off-target-free RNA silencing', Nature Structural and Molecular Biology, 31, pp. 1702 - 1716, http://dx.doi.org/10.1038/s41594-024-01336-0

Hassan N; Yi H; Malik B; Gaspard-Boulinc L; Samaraweera SE; Casolari DA; Seneviratne J; Balachandran A; Chew T; Duly A; Carter DR; Cheung BB; Norris M; Haber M; Kavallaris M; Marshall GM; Zhang XD; Liu T; Wang J; Liebermann DA; D'Andrea RJ; Wang JY, 2024, 'Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML', Blood, 144, pp. 84 - 98, http://dx.doi.org/10.1182/blood.2024024072

Lau LMS; Khuong-Quang DA; Mayoh C; Wong M; Barahona P; Ajuyah P; Senapati A; Nagabushan S; Sherstyuk A; Altekoester AK; Fuentes-Bolanos NA; Yeung V; Sullivan A; Omer N; Diamond Y; Jessop S; Battaglia L; Zhukova N; Cui L; Lin A; Gifford AJ; Fleuren EDG; Dalla-Pozza L; Moore AS; Khaw SL; Eisenstat DD; Gottardo NG; Wood PJ; Tapp H; Alvaro F; McCowage G; Nicholls W; Hansford JR; Manoharan N; Kotecha RS; Mateos MK; Lock RB; Tyrrell V; Haber M; Trahair TN; Cowley MJ; Ekert PG; Marshall GM; Ziegler DS; Wong-Erasmus M, 2024, 'Precision-guided treatment in high-risk pediatric cancers', Nature Medicine, 30, pp. 1913 - 1922, http://dx.doi.org/10.1038/s41591-024-03044-0

Karsa M; Xiao L; Ronca E; Bongers A; Spurling D; Karsa A; Cantilena S; Mariana A; Failes TW; Arndt GM; Cheung LC; Kotecha RS; Sutton R; Lock RB; Williams O; de Boer J; Haber M; Norris MD; Henderson MJ; Somers K, 2024, 'FDA-approved disulfiram as a novel treatment for aggressive leukemia', Journal of Molecular Medicine, 102, pp. 507 - 519, http://dx.doi.org/10.1007/s00109-023-02414-4

Hogarty MD; Ziegler DS; Franson A; Chi YY; Tsao-Wei D; Liu K; Vemu R; Gerner EW; Bruckheimer E; Shamirian A; Hasenauer B; Balis FM; Groshen S; Norris MD; Haber M; Park JR; Matthay KK; Marachelian A, 2024, 'Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial', British Journal of Cancer, 130, pp. 788 - 797, http://dx.doi.org/10.1038/s41416-023-02525-2

Mayoh C; Gifford AJ; Terry R; Lau LMS; Wong M; Rao P; Shai-Hee T; Saletta F; Khuong-Quang DA; Qin V; Mateos MK; Meyran D; Miller KE; Yuksel A; Mould EVA; Bowen-James R; Govender D; Senapati A; Zhukova N; Omer N; Dholaria H; Alvaro F; Tapp H; Diamond Y; Pozza LD; Moore AS; Nicholls W; Gottardo NG; McCowage G; Hansford JR; Khaw SL; Wood PJ; Catchpoole D; Cottrell CE; Mardis ER; Marshall GM; Tyrrell V; Haber M; Ziegler DS; Vittorio O; Trapani JA; Cowley MJ; Neeson PJ; Ekert PG, 2023, 'A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer', Genome Medicine, 15, http://dx.doi.org/10.1186/s13073-023-01170-x

Murray J; Pandher R; Xiao L; Somers K; Brand J; Mosmann E; Alfred S; Kusuma F; Kearns A; Park JR; Marshall LV; Gorrini C; Chesler L; Hogarty MD; Pearson ADJ; Burns M; Fletcher JI; Ziegler D; Norris MD; Haber M, 2023, 'Abstract B132: Addition of AMXT1501 (polyamine uptake inhibitor) plus DFMO (polyamine synthesis inhibitor) to standard-of-care chemotherapy/anti-GD2 antibody in the TH-MYCN mouse neuroblastoma model, enhances efficacy compared to addition of DFMO alone', Molecular Cancer Therapeutics, 22, pp. b132 - b132, http://dx.doi.org/10.1158/1535-7163.targ-23-b132

Ajuyah P; Mayoh C; Lau LMS; Barahona P; Wong M; Chambers H; Valdes-Mora F; Senapati A; Gifford AJ; D’Arcy C; Hansford JR; Manoharan N; Nicholls W; Williams MM; Wood PJ; Cowley MJ; Tyrrell V; Haber M; Ekert PG; Ziegler DS; Khuong-Quang DA, 2023, 'Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes', Scientific Reports, 13, pp. 3775, http://dx.doi.org/10.1038/s41598-023-30395-4

Wakefield CE; Hetherington K; Robertson EG; Donoghoe MW; Hunter JD; Vetsch J; Marron JM; Tucker KM; Marshall GM; Broom A; Haber M; Tyrrell V; Malkin D; Lau L; Mateos MK; O’Brien TA; Ziegler DS, 2023, 'Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives', British Journal of Cancer, 129, pp. 1634 - 1644, http://dx.doi.org/10.1038/s41416-023-02429-1

Zhai L; Balachandran A; Larkin R; Seneviratne JA; Chung SA; Lalwani A; Tsubota S; Beck D; Kadomatsu K; Beckers A; Durink K; De Preter K; Speleman F; Haber M; Norris MD; Swarbrick A; Cheung BB; Marshall GM; Carter DR, 2023, 'Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma', International Journal of Molecular Sciences, 24, http://dx.doi.org/10.3390/ijms242115571

Mayoh C; Mao J; Xie J; Tax G; Chow SO; Cadiz R; Pazaky K; Barahona P; Ajuyah P; Trebilcock P; Malquori A; Gunther K; Avila A; Yun DY; Alfred S; Gopalakrishnan A; Kamili A; Wong M; Cowley MJ; Jessop S; Lau LMS; Trahair TN; Ziegler DS; Fletcher JI; Gifford AJ; Tsoli M; Marshall GM; Haber M; Tyrrell V; Failes TW; Arndt GM; Lock RB; Ekert PG; M Dolman ME; Wong-Erasmus M; Ajuyah P, 2023, 'High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer', Cancer Research, 83, pp. 2716 - 2732, http://dx.doi.org/10.1158/0008-5472.CAN-22-3702

Daly R; Hetherington K; Hazell E; Wadling BR; Tyrrell V; Tucker KM; Marshall GM; Ziegler DS; Lau LMS; Trahair TN; O’Brien TA; Collins K; Gifford AJ; Haber M; Pinese M; Malkin D; Cowley MJ; Karpelowsky J; Drew D; Jacobs C; Wakefield CE, 2023, 'Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial', Journal of Personalized Medicine, 13, http://dx.doi.org/10.3390/jpm13071033

Back to profile page